We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Practices for Preventing Polypharmacy in Multiple Sclerosis
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Ahmed Zayed Obeidat, MD, PhD
Lauren Beranek, BS
From Assessment to Management: Tackling Catatonia in Schizophrenic Patients
Ashley Baker, MSN, PMHNP
Stanley N. Caroff, MD
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Charles Turck, PharmD, BCPS, BCCCP
Jagan Pillai, MD, PhD
Advancements in Multiple Sclerosis: Insights from the 2024 ACTRIMS Forum
Exploring the Latest in MS Cognitive Rehabilitation Strategies
Nancy Chiaravalloti, PhD
Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics
Daniel Harrison, MD
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
Anna Shah, MD
Unmet Needs in Rehabilitation Research for Multiple Sclerosis
Robert Motl, PhD
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging
Yinan Zhang, MD
Telehealth in MS Care: Addressing the Potential for Improvement and Concerns
Marisa McGinley, DO
Addressing Healthcare Barriers in Patients with Multiple Sclerosis
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Andrew Wilner, MD, FACP, FAAN
Marcus E. Peter, PhD
Schizophrenia Diagnosis: The Importance of a Collaborative Approach
Morris Goldman, MD
Dara Sanandaji
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
George Bloom, PhD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education